Effect of omeprazole on vacuole size in Coxiella burnetii-infected cells

Journal of Infection

Volumn 66, Issue 3, 2013, Pages 288-289

  Botelho Nevers, Elisabeth ^a   Singh, Sudhir ^a   Chiche, Laurent ^b   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; OMEPRAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELL VACUOLE; CELL VACUOLE SIZE; CELLULAR PARAMETERS; COM1 GENE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COXIELLA BURNETII; DRUG CYTOTOXICITY; DRUG POTENTIATION; GENE; GROWTH INHIBITION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LETTER; NONHUMAN; Q FEVER;

COXIELLA BURNETII; FIBROBLASTS; HUMANS; LUNG; OMEPRAZOLE; Q FEVER; VACUOLES;

EID: 84873262630     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.10.006     Document Type: Letter

References (13)

1. Maurin M., Benoliel A.M., Bongrand P., Raoult D. Phagolysosomes of Coxiella burnetii-infected cell line maintain an acidic pH during persistent infection. Infect Immun 1992, 60(12):5013-5016.
2. Raoult D., Tissot-Dupont H., Foucault C., Gouvernet J., Fournier P.E., Bernit E., et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000, 79:109-123.
3. Botelho-Nevers E., Fournier P.E., Richet H., Fenollar F., Lepidi H., Foucault C., et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 2007, 26:635-640.
4. Million M., Thuny F., Richet H., Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010, 10:527-535.
5. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother 1990, 34(8):1512-1514.
6. Rolain J.M., Lambert F., Raoult D. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Ann N Y Acad Sci 2005, 1063:252-256.
7. Maurin M., Raoult D. Q fever. Clin Microbiol Rev 1999, 12:518-553.
8. Maurin M., Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. Antimicrob Agents Chemother 1993, 37:2633-2637.
9. Botelho-Nevers E., Espinosa L., Raoult D., Rolain J.M. Lovastatin, but not pravastatin, limits in vitro infection due to Coxiella burnetii. J Antimicrob Chemother 2008, 62:845-847.
10. Minnick M.F., Hicks L.D., Battisti J.M., Raghavan R. Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro. Int J Antimicrob Agents 2010, 36:380-382.
11. Jiang S., Meadows J., Anderson S.A., Mukkada A.J. Antileishmanial activity of the antiulcer agent omeprazole. Antimicrob Agents Chemother 2002, 46:2569-2574.
12. Maurin M., Benoliel A.M., Bongrand P., Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis 1992, 166(5):1097-1102.
13. Gill S.K., O'Brien L., Einarson T.R., Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol 2009, 104:1541-1545.